CIK 0001455365 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
COGNITION THERAPEUTICS INC
Sign in to watch- Ticker
- CGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 412-481-2210
- Business address
- 2500 WESTCHESTER AVE, PURCHASE, NY, 10577
- Former names
- COGNITION THERAPUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-13 | Fletcher Aaron G.L. Director | Option exercise · Warrant (right to buy) | −33,495 | 0 | ||
| 2021-10-13 | Fletcher Aaron G.L. Director | Conversion · Simple Agreement for Future Equity | −24,263 | 0 | ||
| 2021-10-13 | Fletcher Aaron G.L. Director | Conversion · Simple Agreement for Future Equity | −158,476 | 0 | ||
| 2021-10-13 | Fletcher Aaron G.L. Director | Conversion · Simple Agreement for Future Equity | −25,593 | 0 | ||
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Conversion | +273,321 | 273,321 | ||
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Conversion | +167,721 | 441,042 | ||
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Conversion | +1,237,959 | 1,679,001 | ||
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Conversion | +486,742 | 2,165,743 | ||
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Option exercise | +12,276 | $0.03 | $393 | 2,178,019 |
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Sale | −33.09 | $12.00 | $397 | 2,177,985 |
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Conversion | +311,706 | 2,489,691 | ||
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Conversion · Series A-1 Convertible Preferred Stock | −884,058 | 0 | ||
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Conversion · Series A-2 Convertible Preferred Stock | −542,496 | 0 | ||
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −4,004,181 | 0 | ||
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Conversion · Series B-1 Convertible Preferred Stock | −1,574,370 | 0 | ||
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Option exercise · Warrant (right to buy) | −12,276 | 0 | ||
| 2021-10-13 | Golden Seeds Cognition Therapeutics LLC 10% owner | Conversion · Simple Agreement for Future Equity | −0 | 0 | ||
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Conversion | +407,916 | 407,916 | ||
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Conversion | +103,055 | 510,971 | ||
| 2021-10-13 | Ogden CAP Associates, LLC 10% owner | Conversion | +272,756 | 783,727 |
Page 11 of 13 · 247 trades